TGTX CIK: 1001316

TG Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.33
FY22:
0.17
FY23:
0.32
FY24:
0.57
FY25:
0.63
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.05
FY22:
0.03
FY23:
0.01
FY24:
0.01
FY25:
0.43
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.38
FY22:
0.19
FY23:
0.33
FY24:
0.58
FY25:
1.06

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.07
FY22:
0.05
FY23:
0.05
FY24:
0.09
FY25:
0.15
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.08
FY22:
0.08
FY23:
0.12
FY24:
0.26
FY25:
0.26
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.24
FY22:
0.06
FY23:
0.16
FY24:
0.22
FY25:
0.65
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.38
FY22:
0.19
FY23:
0.33
FY24:
0.58
FY25:
1.06

All amounts in billions USD Data source:SEC EDGAR